Richard Lau
Richard Lau has made 70 investments in companies such as: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology, Jounce Therapeutics, Wave Life Sciences, LifeMine Therapeutics, Peloton Therapeutics, 10X Genomics, Ardelyx, Adaptimmune, Cullinan Oncology, Kira Pharmaceuticals, Generation Bio, Relay Therapeutics, Protagonist Therapeutics, Decibel Therapeutics, Alector, Cue, Orchard Therapeutics, Crossover Health, Audentes Therapeutics, Tarsa Therapeutics, Verona Pharma, Aduro BioTech, Juvenescence, Genomics, Intarcia Therapeutics, Turning Point Therapeutics, Akari Therapeutics, Genapsys, Cerevance, SomaLogic, Bit Bio, Affinivax, Fulcrum Therapeutics, Inscripta, Intellia Therapeutics, Maze Therapeutics, Replimune Group, ALX Oncology, WaveTec Vision, Tempest Therapeutics, evonetix, HealthVerity, ORIC Pharmaceuticals, EverlyWell, Tasso, Vaxcyte, Delfi Diagnostics, Sequenta, REGENXBIO, Solid Biosciences, Keros Therapeutics, Nexvet, Venatorx Pharmaceuticals, Insitro, VelosBio, Mindstrong, Kinnate Biopharma, Kriya Therapeutics, Twist Bioscience, Aimmune Therapeutics, Element Biosciences, Pharvaris, Arcus Biosciences, DNAnexus, Nurix Therapeutics, Ivantis, SAGE Therapeutics.
Location of Richard Lau is San Francisco, United States.The free version of Angel Match provides limited data for Richard Lau. Advanced features and premium data such as emails, phone numbers and social media profiles are available only on paid subscription plans.
Richard Lau is a Director and he his investment types are: Private Equity Firm.
Richard Lau focuses investing in industries such as: Biotechnology, Health Care, Medical, Therapeutics, Analytics, Artificial Intelligence, Life Science, Pharmaceutical, Software, Women Led, Information Technology, Travel, Women Founded, Health Diagnostics, Hospital.
A short brief about investor:
About
Investor type:
Locations:
Past investments
- AveXis
- Remix Therapeutics
- Karyopharm Therapeutics
- Olema Oncology
- Jounce Therapeutics
- Wave Life Sciences
- LifeMine Therapeutics
- Peloton Therapeutics
- 10X Genomics
- Ardelyx
- Adaptimmune
- Cullinan Oncology
- Kira Pharmaceuticals
- Generation Bio
- Relay Therapeutics
- Protagonist Therapeutics
- Decibel Therapeutics
- Alector
- Cue
- Orchard Therapeutics
- Crossover Health
- Audentes Therapeutics
- Tarsa Therapeutics
- Verona Pharma
- Aduro BioTech
- Juvenescence
- Genomics
- Intarcia Therapeutics
- Turning Point Therapeutics
- Akari Therapeutics
- Genapsys
- Cerevance
- SomaLogic
- Bit Bio
- Affinivax
- Fulcrum Therapeutics
- Inscripta
- Intellia Therapeutics
- Maze Therapeutics
- Replimune Group
- ALX Oncology
- WaveTec Vision
- Tempest Therapeutics
- evonetix
- HealthVerity
- ORIC Pharmaceuticals
- EverlyWell
- Tasso
- Vaxcyte
- Delfi Diagnostics
- Sequenta
- REGENXBIO
- Solid Biosciences
- Keros Therapeutics
- Nexvet
- Venatorx Pharmaceuticals
- Insitro
- VelosBio
- Mindstrong
- Kinnate Biopharma
- Kriya Therapeutics
- Twist Bioscience
- Aimmune Therapeutics
- Element Biosciences
- Pharvaris
- Arcus Biosciences
- DNAnexus
- Nurix Therapeutics
- Ivantis
- SAGE Therapeutics